• No results found

Nikolaos Papadimitriou Cell Therapy in Intervertebral Disc Degeneration

N/A
N/A
Protected

Academic year: 2022

Share "Nikolaos Papadimitriou Cell Therapy in Intervertebral Disc Degeneration"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

2021

ISBN 978-91-8009-280-7 (PRINT) ISBN 978-91-8009-281-4 (PDF) http://hdl.handle.net/2077/67641 Printed by Stema Specialtryck AB, Borås

Cell Therapy in Intervertebral Disc Degeneration | Nikolaos Papadimitriou

DOCTORAL THESIS

SAHLGRENSKA ACADEMY

Cell Therapy in

Intervertebral Disc Degeneration

Nikolaos Papadimitriou

SAHLGRENSKA ACADEMY

INSTITUTE OF CLINICAL SCIENCES

References

Related documents

The GDF5+ cells and smaller cells (GDF5+ cells are included in this population) displayed a better migration capability compared to large cells. This is in alignment

Results: a potential stem cell niche was identified in the IVD region lateral to the epihyseal plate and in the annulus fibrosus outer region, based on findings of label-retaining

Treatment approaches using growth factors, cell therapy and extracellular vesicles (EVs) derived from human mesenchymal stem cells (hMSCs) could improve

The main part of the thesis consists of a detailed commentary on some sixty neologisms of various types that occur in 2 Maccabees: neologisms first attested in this book,

Patients in clinical relapse exhibited higher levels of FoxP3 positive Treg cells lacking both CD127 and CD25 compared to patients in remission (p<0,01) indicating that

[r]

(dASCs) reduce muscle atrophy. In this thesis work, we studied the possible mechanisms underlying the re- generative potential of both SVF and culture expanded dASCs. Hypotheses:

Due to the limitations with tested cell sources, this project is aimed to investigate the feasibility of human blood cells as new alternative cell source for a potential cell